Telerehabilitation for Rural Patients with Advanced Prostate Cancer

This study is looking at how a special program called Telerehabilitation Unit can help men with advanced prostate cancer who live in rural areas. This program uses technology to deliver rehabilitation services right to your home. It includes a touchscreen tablet, a portable bike, elastic bands, and a pulse oximeter (a device that measures oxygen in your blood). The goal is to see if this program is acceptable to patients and if it improves their quality of life, measured by a survey called Functional Assessment of Cancer Therapy-Prostate (FACT-P). You may be able to join if you are a man aged 18 or older with confirmed prostate cancer, are receiving standard hormone therapy (ADT), and live in a rural community. The study is currently recruiting about 30 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll about 30 men.
What's involved
Participants will use the Telerehabilitation Unit for up to 12 weeks. This involves using a touchscreen tablet, a portable bike, elastic bands, and a pulse oximeter at home.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 12 weeks after starting the study intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07093177

Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer

Recruiting
NAAges 18+InterventionalSupportive care
University of Utah
~30 participants
Updated 2026-04-13 on ClinicalTrials.gov
What's tested:Telerehabilitation Unit

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability
Measured over up to 12-week after initiation of study intervention
+1 more outcome measured
Prostate Cancer
1 sites across 1 states
Utah1
  • Manish Kohli, MD · PRINCIPAL_INVESTIGATOR · Huntsman Cancer Institute

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 and older
Confirmed diagnosis of prostate cancer
Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of metastatic prostate cancer
Residing in a rural community, as indicated by zip code in RUCA areas

Exclusion

Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures
Engaged in a regular exercise rehabilitation program
Relocation plans within next 3 months
Participating in another clinical trial
Have a working telephone line in their home or a cell phone.
  • Acceptabilityup to 12-week after initiation of study intervention

    To evaluate system usability, acceptability, and exercise adherence of 12-week multimodal telerehabilitation. The acceptability of telerehabilitation will be assessed using the Client Satisfaction Questionnaire (CSQ). The CSQ is an 8-item questionnaire measuring the acceptability and patient satisfaction of the multimodal telerehabilitation. CSQ scores range from 8 to 32, with lower scores indicating lower satisfaction and higher scores indicating better satisfaction. An average CSQ score \> 20 will indicate satisfactory acceptability.

  • Functional Assessment of Cancer Therapy-Prostate (FACT-P)up to 12-week after initiation of study intervention

    To assess the range of responses to the telerehabilitation program by measuring disease-specific quality of life (QOL). FACT-P is a 5-point Likert scale from "0 Not at all" to "4 Very much". The FACT-P is a 39-item questionnaire with a minimum score of 0 and a maximum score of 156. Lower scores indicate worse QOL, and higher scores indicate better QOL. This outcome measure will report the mean FACT-P total score.